Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:52:59 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:TTOO - T2 BIOSYSTEMS INC - http://www.t2biosystems.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TTOO - Q0.12.92·3.000.12.97-0.02-0.730.2802133.01  3.07  2.9270.00  2.7015:31:34Apr 1115 min RT 2¢

Recent Trades - Last 10 of 213
Time ETExPriceChangeVolume
15:31:34Q2.9639-0.026125
15:30:35Q2.965-0.0251
15:29:45Q2.9632-0.026810
15:25:16Q2.94-0.0510
15:25:16Q2.99 3
15:23:55Q2.955-0.0352
15:21:54Q2.975-0.0153
15:21:54Q2.975-0.0151
15:20:59Q2.945-0.04518
15:20:52Q2.97-0.025

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-11 16:05U:TTOONews ReleaseT2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
2024-03-28 09:00U:TTOONews ReleaseT2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
2024-03-20 07:30U:TTOONews ReleaseT2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
2024-03-19 09:00U:TTOONews ReleaseT2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
2024-03-18 09:00U:TTOONews ReleaseT2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
2024-03-12 09:00U:TTOONews ReleaseT2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
2024-02-15 16:06U:TTOONews ReleaseT2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
2024-02-15 16:04U:TTOONews ReleaseT2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
2024-02-15 16:02U:TTOONews ReleaseT2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
2024-02-12 09:00U:TTOONews ReleaseT2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
2024-02-07 16:05U:TTOONews ReleaseT2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
2024-02-07 09:00U:TTOONews ReleaseU.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
2024-01-18 09:00U:TTOONews ReleaseT2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients
2024-01-03 09:00U:TTOONews ReleaseT2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing
2023-11-03 09:00U:TTOONews ReleaseT2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
2023-11-01 09:00U:TTOONews ReleaseT2 Biosystems Regains Compliance with Nasdaq Listing Requirements
2023-10-24 16:05U:TTOONews ReleaseT2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
2023-10-23 09:00U:TTOONews ReleaseT2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
2023-10-12 16:05U:TTOONews ReleaseT2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
2023-10-12 16:02U:TTOONews ReleaseT2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii